Pricing Log in Create free account

Orgenesis Inc. (ORGS) vs Exicure, Inc. (XCUR)

Orgenesis Inc. and Exicure, Inc. are both Biotechnology companies. Orgenesis Inc. and Exicure, Inc. are of similar size ($5.8M and $5.7M). Exicure, Inc. grew revenue faster over the last twelve months: 2,366.5% against 95.3%. Exicure, Inc. has the higher net margin (0.00% vs −4,653.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Exicure, Inc. leads on 13 and Orgenesis Inc. on 3.

Valuation

Metric ORGS XCUR Biotechnology median
P/E n/m n/m 10.60
P/S 1.42 0.22 9.40
P/B n/m 5.94 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 16.89 0.19 9.02
Earnings yield (3,288.57%) (145.05%) (32.88%)
Free cash flow yield (1,176.50%) (102.61%) (23.13%)

Profitability

Metric ORGS XCUR Biotechnology median
Gross margin (86.28%) 80.08% 68.51%
Operating margin (3,842.32%) 0.00% 0.00%
Net margin (4,653.62%) 0.00% 0.00%
Free cash flow margin (1,675.27%) 0.00% 0.00%
Return on equity 164.62% (168.37%) (51.96%)
Return on assets (605.73%) (54.98%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ORGS XCUR Biotechnology median
Revenue growth (TTM) 95.28% 2,366.45% 6.76%
EPS growth (last fiscal year) 40.10% 83.37% 29.88%
Revenue growth, 5-year CAGR (23.30%) 33.48% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ORGS XCUR Biotechnology median
Debt to equity (0.44) 0.00 0.00
Current ratio 0.03 0.56 4.97
Net debt to EBITDA (0.42) 0.99 1.01

Dividend

Metric ORGS XCUR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ORGS XCUR Biotechnology median
Market cap 5.68m 5.83m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack